[Cholestatic icterus induced by the administration of fusidic acid in a cirrhotic patient]

Presse Med. 2002 Jun 29;31(23):1083-4.
[Article in French]

Abstract

Introduction: Fucidic acid is an antibiotic essentially used to treat staphylococcal infections. Its chemical structure is very similar to that of bilary acids and hence implies competitive mechanisms between their elimination and metabolization.

Observation: A patient with a past history of alcohol-induced cirrhosis was treated with fucidic acid for a Staphylococci aureus urinary infection. On day 2 of treatment a conjugate bilirubine icterus appeared. There was no argument to suggest a decompensation of the icterus. The icterus disappeared on suspension of fucidic acid.

Comments: The occurrence of an icterus in a cirrhotic patient may evoke decompensation of the hepatopathy and an extensive exploration must be made. A thorough survey of all drug administration must be made. Notably, the possibility of the occurrence of a connective bilirubin icterus during treatment with fucidic acid must be known. The icterus always regresses on withdrawal of treatment and this etiology must be evoked before conducting invasive examinations.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Cholestasis / chemically induced*
  • Fusidic Acid / adverse effects*
  • Fusidic Acid / therapeutic use
  • Humans
  • Liver Cirrhosis / complications*
  • Male
  • Middle Aged
  • Staphylococcal Infections / drug therapy
  • Urinary Tract Infections / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Fusidic Acid